Skip to content

Japanese prospective multicenter study on outpatient cardiac rehabilitation after the percutaneous coronary intervention

Japanese prospective multicenter study on outpatient cardiac rehabilitation after the percutaneous coronary intervention - J-REHAB PCI

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000005177
Enrollment
400
Registered
2011-03-03
Start date
2011-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with ischemic heart disease except for acute myocardial infarction received an elective or emergency percutaneous coronary intervention (PCI) with a drug eluting stent (DES) within 1 month

Interventions

outpatient cardiac rehabilitation followed the cardiac rehabilitation program usual care

Sponsors

ational Cerebral and Cardiovascular Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with ischemic heart disease except for acute myocardial infarction received an elective or emergency PCI with a DES within 1 month and have two or more following risk factors, 1) diabetes mellitus or glucose intolerance, 2) hypertension, 3) hyperlipidemia (LDL≥140mg/dL, HDL<40mg/dL, TG≥150mg/dL at enrollment) 4) BMI≥25, 5) smoking. In addition, patients who have no contraindication to the rehabilitation.

Exclusion criteria

Exclusion criteria: 1) Patients received a PCI after acute myocardial infarction, 2) Patients who experienced cerebrovascular disease or orthopedic disease which are impediments to the exercise, 3) chronic renal failure (Cr>3.0mg/dL), 4) hepatopathy (GPT>200U/L), 5) other diseases which are impediments to the exercise, 6) CABG within 3 month, 7) future plan of CAGB, 8) patients who are difficult to receive the outpatient rehabilitation

Design outcomes

Primary

MeasureTime frame
cardiac death (including sudden death) or ischemic heart disease

Secondary

MeasureTime frame
1) cardiac disease requiring hospitalization, 2) exercise tolerability, 3) Quality of Life (SF-36, SDS, SAS), 4) change of cardiac risk factors (HbA1c, TG, HDL-C, high-sensitive CRP)

Countries

Japan

Contacts

Public ContactYoichi GOTO

National Cerebral and Cardiovascular Center Cardiovascular Division

kkatayam@ncvc.go.jp06-6833-5012

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026